Adalimumab (tumor necrosis factor-blocker) reduces the expression of glial fibrillary acidic protein immunoreactivity increased by exogenous tumor necrosis factor alpha in an organotypic culture of porcine neuroretina

PURPOSE: To determine if exogenous addition of tumor necrosis factor alpha (TNFα) exacerbates retinal reactive gliosis in an organotypic culture of porcine neuroretina and to evaluate if concomitant adalimumab, a TNF-blocker, diminishes it. METHODS: Porcine retinal explants from 20 eyeballs were cul...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandez-Bueno, I., Garcia-Gutierrez, M.T., Srivastava, G.K., Gayoso, M.J., Gonzalo-Orden, J.M., Pastor, J.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Vision 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654850/
https://www.ncbi.nlm.nih.gov/pubmed/23687426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654850/
https://www.ncbi.nlm.nih.gov/pubmed/23687426

Ejemplares similares